Question 1

What are the most cited papers from Synimmune (Germany)?

Accepted Answer

The most cited paper from Synimmune (Germany) is "Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit in vivo leukemia growth" (Sarah Oelsner, Anja Waldmann, Arne Billmeier et al., 2019), with 87 citations. Next come "Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia" (57) and "γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay" (48).

Question 2

Which research topics does Synimmune (Germany) publish most on?

Accepted Answer

By volume in 2022-now: RNA and protein synthesis mechanisms, Advanced biosensing and bioanalysis techniques, Force Microscopy Techniques and Applications and Acute Myeloid Leukemia Research.

Question 3

Which fields of science does Synimmune (Germany) work in?

Accepted Answer

In all years, 50% of research at Synimmune (Germany) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (50%), Biochemistry, Genetics and Molecular Biology (28%), Immunology and Microbiology (9%).

Question 4

Is Synimmune (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 78% lower than in 2018-2021.